Paper Details

  1. Home
  2. Paper Details

Single-day therapy for recurrent genital herpes.

Author: BergerTim, HamedKamal, TharpMichael, TyringStephen, Yen-MooreAngela

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Genital herpes, an incurable viral infection affecting one in four Americans, can have a significant impact on people's lives. While standard treatment involves antiviral medications for 3-5 days, a single-day treatment may be more effective, as most viral replication occurs within the first 24 hours of symptoms. A study found that single-day famciclovir reduced healing time, pain duration, and the number of patients experiencing a full outbreak compared to placebo. The results were comparable to or better than conventional 2-5 day treatments. The convenience of single-day treatment could encourage patients to use it more consistently, improving overall management of recurrent outbreaks.
Paper Details　
Original Abstract of the Article :
Genital herpes, an incurable viral disease that can have a devastating impact on affected patients, is a serious public health concern affecting one in four Americans. Episodic treatment with nucleoside analogs for 3-5 days is the most common method of treatment; however, since maximum viral replica...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2165/00128071-200607040-00001

データ提供：米国国立医学図書館（NLM）

Single-Day Therapy: A More Convenient Approach to Genital Herpes

Genital herpes is a common and often uncomfortable viral infection that can have a significant impact on individuals' lives. The conventional treatment for recurrent outbreaks typically involves the use of nucleoside analogs for 3-5 days. This study examines a more convenient approach, investigating the effectiveness of patient-initiated single-day famciclovir therapy for genital herpes. The study found that single-day famciclovir therapy was just as effective, if not more effective, than conventional multi-day therapies in reducing healing time, duration of pain, and overall symptoms associated with outbreaks.

The Convenience Factor: Why Single-Day Therapy Might Win

The study highlights the significant advantage of single-day therapy in terms of patient convenience. The results suggest that this approach could lead to greater adherence to treatment regimens and, ultimately, improved management of recurrent herpes outbreaks. This is an important finding, as adherence to long-term medication regimens can be challenging for many individuals, especially when dealing with a condition like genital herpes.

Empowering Patients to Take Control of Their Health

The development of single-day therapy for genital herpes offers a more convenient and potentially more effective option for patients. This approach allows individuals to take control of their health by initiating treatment themselves at the first sign of an outbreak.

Dr. Camel's Conclusion

Imagine a bustling marketplace where people are rushing around, seeking cures for various ailments. This study, like a wise old camel, navigates through the crowds, offering a simple but effective remedy for recurrent genital herpes. Single-day therapy provides a convenient solution, empowering individuals to manage their condition with ease and confidence.

Date :
  1. Date Completed 2006-12-15
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16901180

DOI: Digital Object Identifier

10.2165/00128071-200607040-00001

Related Literature

Article Analysis
・Effective treatment of genital herpes
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.